Immunohistochemical evaluation of p62/SQSTM1 may be a potential significant marker to identify early carcinogenesis, chemo-radiotherapeutic resistance or poor prognosis of oral squamous cell carcinomas. This evidence concerns the gene SQSTM1 and oral cavity squamous cell carcinoma.